A Study Now Shows Sex Difference in Alzheimer’s Risk and Progression

(Newswire.net — April 12, 2022) Orlando, FL — Globally, almost 44 million people suffer from Alzheimer’s disease or related dementia. Unfortunately, only 1 in 4 individuals with Alzheimer’s got a diagnosis. In Western Europe, Alzheimer’s and dementia are most common.

By 2050, the costs linked with dementia could reach as much as $1.1 trillion. It is also worth mentioning that such a condition is estimated to cost $605 billion, and this equates to 1 percent of the entire world’s gross domestic product.

Due to the increasing prevalence of dementia, more and more researchers are looking to find some helpful clues to learn more about its risk and progression. 

A study was carried out by researchers from the Center for Cognitive Medicine (CCI) at Vanderbilt University Medical Center.

Researchers say that the abnormal buildup of proteins in the brain is a biological marker for Alzheimer’s disease. However, according to this study, the ways in which these proteins spread may aid in explaining why the rates of Alzheimer’s tend to be higher in women than in men.

The findings were presented at the Alzheimer’s Association International Conference on July 14-18 in Los Angeles.

More particularly, the investigators found differences in the spread of tau between men and women. It is worth mentioning Tau is a protein linked with cognitive impairment.

The findings have shown women had a larger brain-wide buildup of tau than men due to an accelerated brain-wide spread.

There are many other studies shedding light on various aspects of Alzheimer’s disease. These include the potential use of some all-natural remedies like Rhodiola Rosea.

Scientists have been carrying out studies to explore more about the healing goodness of Rhodiola, which is native to mountainous regions of Europe, Asia, and the Arctic.

Rhodiola is particularly known for its ability to decrease stress and, in some studies, its potential to aid in memory loss. Due to this, it has become a subject of aging and Alzheimer’s disease.

According to researchers, Rhodiola may aid in slowing the breakdown of the neurotransmitter acetylcholine, which is associated with memory. 

In a study involving rats with signs of Alzheimer’s disease, it has been found that it enhances the symptoms of the subjects. These symptoms include stress, fatigue, and depression which are the conditions Rhodiola has long been known to treat.

Aside from its remarkable brain health benefits, Rhodiola has also been known to work wonders in delivering a range of disease-fighting effects. It can be obtained through the use of formulas like Divine Bounty Rhodiola Rosea ( http://www.amazon.com/Rhodiola-Rosea-Supplement-Siberian-Salidroside/dp/B07416DYPB).